ALEC Alector, Inc.

NEUTRAL Impact: 3/10 Insider Cluster (3 insiders)
Horizon days Filed Jun 3, 2026 Processed 11d 10h ago
Insider cluster: 2 insiders, $210K total
Latest settled — T+1d
ALEC ▼ -9.67% at T+1d
NEUTRAL call ✗ call lost -9.67% · α vs SPY -7.07% · entry $1.81 → $1.64
Next anchor: T+5d due 5d ago
Last close $1.53 (close Jun 12) · -15.47% from $1.81 entry
Entry anchored
Jun 3, 2026
via day open
T+1d
-9.67%
call -9.67% · α -7.07%
$1.64
settled 11d ago
T+5d
call — · α —
due 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Arnon Rosenthal and CFO Neil Berkley sold a combined $210K in open-market sales on June 2, 2026, with the CEO alone accounting for $172K. The cluster represents ~0.1% of Alector's $216M market cap, falling at the trivial-to-modest threshold. Historical calibration on this ticker shows poor predictive accuracy (25% win rate at T+20), and the dollar amount is too small to signal material insider concern.

Key Financial Metrics

Direction
selling
Total Value
$228.0K
Insiders
3

Actionable Insight

The dollar amount is too small relative to market cap to be material. Monitor for any upcoming 8-K filings (earnings, pipeline updates, or financing) that could explain the timing, but the cluster alone does not warrant a bearish stance.

Key Facts

  • CEO Arnon Rosenthal sold 87,216 shares at $1.97 for $172K on June 2, 2026
  • CFO Neil Berkley sold 19,360 shares at $1.97 for $38K on June 2, 2026
  • Total cluster value of $210K represents ~0.1% of Alector's $216M market cap
  • Principal Accounting Officer Grace Wong-Sarad also sold 9,184 shares ($18K) on June 2-3, 2026
  • All sales were open-market transactions; no 10b5-1 plan designation noted

Financial Impact

Total insider sales of $228K over the cluster window, representing ~0.1% of market cap

dilution

Risk Factors

  • CEO selling 87K shares could be perceived negatively by retail investors despite small relative size
  • No 10b5-1 plan disclosed — sales may be opportunistic rather than scheduled
  • Historical calibration shows model has been directionally wrong on ALEC (25% win rate at T+20)

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
57% bullish (14 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ALEC-1780522247847
6 reports for ALEC
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +25.45%Mar 12, 2026
Filters
Rows
Reports for ALEC — sortable, filterable
Type Now
Jun 11, 2026
3d ago
Institutional Cluster
NEUTRAL ★ 4/10
$1.53 awaiting T+1awaiting T+1$1.53 (−0.00%)
Jun 3, 2026
11d ago
Insider Cluster
NEUTRAL ★ 3/10
$1.81 $1.64▼ −9.67%▼ −7.07%$1.53 (−15.47%)
May 7, 2026
5w ago
8-K
BEARISH ★ 6/10
$2.10 $2.05▲ +2.38%▲ +2.61%$1.53 (+27.14%)
Mar 12, 2026
13w ago
S-3
BEARISH ★ 7/10
$2.20 $2.21▼ −0.45%▲ +0.57%$1.53 (+30.45%)
Mar 2, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$2.21 $2.11▲ +4.52%▲ +3.61%$1.53 (+30.77%)
Feb 26, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.56 $2.43▼ −5.08%▼ −4.63%$1.53 (−40.23%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 5h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access